Shan Lang

646 total citations
20 papers, 489 citations indexed

About

Shan Lang is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Shan Lang has authored 20 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Shan Lang's work include Pancreatic function and diabetes (11 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (5 papers). Shan Lang is often cited by papers focused on Pancreatic function and diabetes (11 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (5 papers). Shan Lang collaborates with scholars based in China, Germany and Canada. Shan Lang's co-authors include Tianpei Hong, Rui Wei, Jin Yang, Liangbiao Gu, Kun Yang, Junling Liu, Yunyi Le, Haining Wang, Xiaona Cui and Tianjiao Wei and has published in prestigious journals such as PLoS ONE, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Shan Lang

19 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shan Lang China 15 236 233 168 104 77 20 489
Jeng‐Yueh Hsiao Taiwan 14 83 0.4× 193 0.8× 85 0.5× 66 0.6× 74 1.0× 18 372
Supreet Kaur United States 9 112 0.5× 67 0.3× 126 0.8× 32 0.3× 112 1.5× 31 453
Virginia Kamvissi Germany 7 159 0.7× 105 0.5× 99 0.6× 58 0.6× 60 0.8× 11 395
Suvi Rasilainen Finland 11 478 2.0× 140 0.6× 150 0.9× 288 2.8× 29 0.4× 21 680
Orit Shevah Israel 12 248 1.1× 295 1.3× 167 1.0× 161 1.5× 87 1.1× 23 685
Brian P. Boerner United States 10 246 1.0× 161 0.7× 144 0.9× 75 0.7× 39 0.5× 13 538
Saskia N. van der Crabben Netherlands 8 49 0.2× 189 0.8× 149 0.9× 146 1.4× 175 2.3× 12 609
Ikuro Matsuba Japan 14 274 1.2× 446 1.9× 153 0.9× 206 2.0× 44 0.6× 37 637
Henning Jansen Germany 11 115 0.5× 83 0.4× 98 0.6× 64 0.6× 69 0.9× 31 427
Abrahim I. Orabi United States 17 705 3.0× 48 0.2× 158 0.9× 81 0.8× 99 1.3× 29 878

Countries citing papers authored by Shan Lang

Since Specialization
Citations

This map shows the geographic impact of Shan Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lang more than expected).

Fields of papers citing papers by Shan Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lang. The network helps show where Shan Lang may publish in the future.

Co-authorship network of co-authors of Shan Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Lang. A scholar is included among the top collaborators of Shan Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Lang. Shan Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Jin, Xia Li, Tianjiao Wei, et al.. (2024). Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin. Diabetes. 73(6). 926–940. 19 indexed citations
3.
Wang, Dandan, Tianjiao Wei, Xiaona Cui, et al.. (2024). Fam3a-mediated prohormone convertase switch in α-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner. Metabolism. 162. 156042–156042. 1 indexed citations
4.
Cui, Xiaona, Jin Feng, Tianjiao Wei, et al.. (2022). Pancreatic alpha cell glucagon–liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes. Diabetologia. 66(3). 535–550. 25 indexed citations
5.
Cui, Xiaona, Jin Feng, Tianjiao Wei, et al.. (2022). Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice. iScience. 25(7). 104567–104567. 18 indexed citations
6.
Tian, Xue, Fenghu Li, Jiehui Li, et al.. (2021). A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study. Cancer Management and Research. Volume 13. 8307–8316. 11 indexed citations
7.
Lang, Shan, Ye Liu, Ran Lu, et al.. (2021). Association between Thyroid Function and Prognosis of COVID-19: A Retrospective Observational Study. Endocrine Research. 46(4). 170–177. 23 indexed citations
8.
Lang, Shan, Rui Wei, Tianjiao Wei, et al.. (2020). Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice. Peptides. 131. 170349–170349. 17 indexed citations
9.
Wei, Rui, Xiaona Cui, Jin Feng, et al.. (2020). Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice. Metabolism. 111. 154324–154324. 73 indexed citations
10.
Lang, Shan, Jin Yang, Kun Yang, et al.. (2020). Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes. BMJ Open Diabetes Research & Care. 8(1). e001025–e001025. 32 indexed citations
11.
Gu, Liangbiao, Xiaona Cui, Shan Lang, et al.. (2019). Glucagon receptor antagonism increases mouse pancreatic δ-cell mass through cell proliferation and duct-derived neogenesis. Biochemical and Biophysical Research Communications. 512(4). 864–870. 17 indexed citations
12.
Liu, Junling, Kun Yang, Jin Yang, et al.. (2019). Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output. EBioMedicine. 41. 73–84. 64 indexed citations
13.
14.
Wei, Rui, Liangbiao Gu, Jin Yang, et al.. (2019). Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice. iScience. 16. 326–339. 32 indexed citations
15.
Li, Fenghu, Mingyuan He, Jiehui Li, et al.. (2019). Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer. Medicine. 98(52). e18513–e18513. 7 indexed citations
16.
Liu, Junling, Kun Yang, Wenhua Xiao, et al.. (2018). GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner. Peptides. 106. 83–90. 17 indexed citations
17.
Xiao, Yongjiu, et al.. (2018). Serum Inflammatory Markers in Patients with Adenovirus Respiratory Infection. Medical Science Monitor. 24. 3848–3855. 31 indexed citations
18.
Lang, Shan, Libing Li, Xuning Wang, et al.. (2017). CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats. PLoS ONE. 12(1). e0169100–e0169100. 53 indexed citations
19.
Xiao, Yongjiu, Shuqing Yu, Shan Lang, et al.. (2017). A scoring system to effectively evaluate central nervous system tuberculosis in patients with miliary tuberculosis. PLoS ONE. 12(5). e0176651–e0176651. 1 indexed citations
20.
Lang, Shan, Junping Sun, Xuning Wang, et al.. (2017). Asymptomatic pulmonary tuberculosis mimicking lung cancer on imaging: A retrospective study. Experimental and Therapeutic Medicine. 14(3). 2180–2188. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeng‐Yueh Hsiao Breakdown of academic impact, for papers by Supreet Kaur Breakdown of academic impact, for papers by Virginia Kamvissi Breakdown of academic impact, for papers by Suvi Rasilainen Breakdown of academic impact, for papers by Orit Shevah Breakdown of academic impact, for papers by Brian P. Boerner Breakdown of academic impact, for papers by Saskia N. van der Crabben Breakdown of academic impact, for papers by Ikuro Matsuba Breakdown of academic impact, for papers by Henning Jansen Breakdown of academic impact, for papers by Abrahim I. Orabi
Rankless by CCL
2026